Product Information
TRIFLUOPERAZINE 2 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.5976 per EA under NDC 00781803201. Its NADAC has been published 219 times since Mar 13, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Sandoz Inc.NDC
00781803201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TRIFLUOPERAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085786FDA Approved
Before 1982
TE Code
AB
On Market Since
11/20/1981
Pharmacological Classes
Price Statistics
The NADAC for TRIFLUOPERAZINE 2 MG TABLET has been published 219 times since Mar 13, 2019, and over the history we have for it it has declined 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5976 per EA |
|---|---|
| All-time high | $0.8266 (Mar 13, 2024) |
| All-time low | $0.5976 (Aug 19, 2026) |
| 52-week high | $0.6798 |
| 52-week low | $0.5976 |
| Median price | $0.7013 |
| Average price | $0.7305 |
| Largest weekly change | +18.0% (Oct 18, 2023) |
| Weeks tracked | 219 |
| Tracking since | Mar 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Trifluoperazine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIFLUOPERAZINE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIFLUOPERAZINE 2 MG TABLET, manufactured by Sandoz Inc., is $0.5976 per EA (NDC 00781803201), effective Aug 19, 2026.
How has the price of TRIFLUOPERAZINE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIFLUOPERAZINE 2 MG TABLET has declined 27.6%. It has been tracked across 219 weekly CMS publications since Mar 13, 2019.
What are the highest and lowest recorded NADAC prices for TRIFLUOPERAZINE 2 MG TABLET?
Since Mar 13, 2019, the NADAC for TRIFLUOPERAZINE 2 MG TABLET has ranged from a low of $0.5976 (Aug 19, 2026) to a high of $0.8266 (Mar 13, 2024), with a median of $0.7013 per EA.
Are there cheaper alternatives to TRIFLUOPERAZINE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TRIFLUOPERAZINE 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIFLUOPERAZINE 2 MG TABLET?
TRIFLUOPERAZINE 2 MG TABLET (NDC 00781803201) is labeled by Sandoz Inc., and CMS classifies it as a generic product.